Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: Value of baseline results to predict the development of new lesions at one year follow up

Acta Neurologica Scandinavica

Volumn 93, Issue 4, 1996, Pages 246-252

  Frederiksen, J L ^a   Petrera, J ^b   Larsson, H B W ^c   Stigsby, B ^b   Olesen, J ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Followup studies; MRI; Multiple sclerosis; Optic neuritis; SEP; VEP; Vibration

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; OPTIC NERVE DISEASE; SCHOOL CHILD;

EID: 0029901617     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00515.x     Document Type: Article

References (36)

1. FREDERIKSEN JL, LARSSON HBW, OLESEN J, STIGSBY B. MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 1991; 83: 343-350.
2. FREDERIKSEN JL, LARSSON HBW, OLESEN J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1992; 82: 312-317.
3. POSER CM, PATY DW, SCHEINBERG L. et al. New diagnostic criteria for multiple sclerosis: guide lines for research protocols. Ann Neurol 1983; 13: 227-231.
4. FREDERIKSEN J, LARSSON HBW, HENRIKSEN O, OLESEN J. Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1989; 80: 512-517.
5. LARSSON H, FREDERIKSEN J, STIGSBY B, OLESEN J. Evaluation of visual pathways in multiple sclerosis. I. After-images compared to visual evoked potentials. Acta Neurol Scand 1986; 74: 195-202.
6. CHRISTIANSEN P, LARSSON HBW, THOMSEN C, WIESLANDER SB, HENRIKSEN O. Age-dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 1994; 35: 117-122.
7. BECKER WJ, RICHARDS IM. Serial pattern shift visual evoked potentials in multiple sclerosis. Can J Neurol Sci 1984; 11: 53-59.
8. HAMMOND SR, MACCALLUM S, YIANNIKAS C, WALSH JC, MCLEOD JG. Variability on serial testing of pattern reversal visual evoked potential latencies from full-field, half-field and foveal stimulation in control subjects. EEG Clin Neurophysiol 1987; 66: 401-408.
9. GHEZZI A, CAPUTO M, ZAFFARONI D, GIUSSANI D, CAZZULLO CL. Electrophysiological tests and cerebrospinal fluid examination in patients with optic neuritis. Acta Neurol Belgica 1983; 85: 80-87.
10. CARROLL WM, HALLIDAY AM, BARRETT G, PERINGER E. Serial VEPs and visual pathway demyelination: a study of 116 patients with multiple sclerosis and isolated optic neuritis. In Nodar RH, Barber C, eds. Evoked potentials II. The Second International Evoked Potential Symposium. Boston: Butterworth Publishers 1984: 310-318.
11. GRUBER H. VEP-Latenzveränderungen nach abgelaufener Retrobulbärneuritis. Klin Mbl Augenheilk 1990; 197: 18-19.
12. HELY MA, MCMANIS PG, WALSH JC, MCLEOD JG. Visual evoked responses and ophthalmological examination in optic neuritis. A follow-up study. J Neurol Sci 1986; 75: 275-283.
13. MATTHEWS WB, SMALL M. Prolonged follow up of abnormal visual evoked potentials in multiple sclerosis. Evidence for delayed recovery. J Neurol Neurosurg Psychiatry 1983; 46: 639-642.
14. HEINRICHS IH, MCLEAN DR. Evolution of visual evoked potentials in optic neuritis. Can J Neurol Sci 1988; 15: 394-396.
15. HARDING GFA, CREWS SJ, GOOD PA. VEP in neuroophthalmic disease. In: Barber C, ed. Evoked potentials. Lancaster: MTP Press 1980: 235-241.
16. CELESIA GG, KAUFMAN DI, BRIGELL M, et al. Optic neuritis. A prospective study. Neurology 1990; 40: 919-923.
17. FREDERIKSEN JL, LARSSON HBW, OTTOVAY E, STIGSBY B, OLESEN J. Acute optic neuritis with normal visual acuity. Comparison of symptoms and signs with psychophysiological, electrophysiological and magnetic resonance imaging data. Acta Ophthalmol 1991; 69: 357-366.
18. SANDERS EACM, VAN LITH GHM. Optic neuritis, confirmed by visual evoked response, and the risk for multiple sclerosis: a prospective survey. J Neurol Neurosurg Psychiatry 1989; 52: 799-810.
19. DE WEERD AW, JONKMAN EJ. Changes in visual and short-latency somatosensory evoked potentials in patients with multiple sclerosis. In: Courjon J, Mauguiere F, Revol M, eds. Clinical applications of evoked potentials in neurology 1982: 527-534.
20. SHAW NA, SYNEK WM. Intersession stability of somatosensory evoked potentials. Electroenceph Clin Neurophysiol 1987; 66: 281-288.
21. ANDERSSON T, PERSSON A. Reproducibility of somatosensory evoked potentials (SEPs) after median nerve stimulation. Electromyogr Clin Neurophysiol 1990: 30: 205-211.
22. MATTHEWS WB. Somatosensory evoked potentials in retrobulbar neuritis. The Lancet 1978: 443.
23. MARTINELLI V, COMI G, FILIPPI M, et al. Paraclinical tests in acute-onset optic neuritis, basal data and results of a short follow up. Acta Neurol Scand 1991; 84: 231-236.
24. HUME AL, WAXMAN SG. Evoked potentials in suspected multiple sclerosis: diagnostic value and prediction of clinical course. J Neurol Sci 1988; 83: 191-210.
25. CHAND RP, DEVI MG. The blink reflex and somatosensory evoked potential in optic neuritis in South India. Acta Neurol Scand 1985; 71: 150-155.
26. CHIAPPA KH. Pattern shift visual, brainstem auditory, and short-latency somatosensory evoked potentials in multiple sclerosis. Neurology 1980; 30(2): 110-123.
27. STOCKHARD JJ, SHARBROUGH FW. Unique contributious of short-latency auditory and somatosensory potentials to neurologic diagnosis. In Desmedt JE, ed. Clinical uses of cerebral brain stem and spinal somatosensory evoked potentials. Progr Clin Neurophysiol 1980; 7: 231-263.
28. ORMEROD IEC, MC DONALD WI, DU BOULAY GH, et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 1986; 49: 124-127.
29. JACOBS L, MUNSCHAUER FB, KABA SE. Clinical and magnetic resonance imaging in optic neuritis. Neurology 1991; 41: 15-19.
30. MILLER DH, ORMEROD IEC, MCDONALD WI, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 1988; 51: 1569-1571.
31. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993; 329: 1764-1769.
32. MORRISSEY SP, MILLER DH, KENDALL BE, et al. Prognostic significance of brain MRI at presentation with a clinical isolated syndrome suggestive of MS-a five-year follow-up study. Brain 1993; 116: 135-146.
33. FILIPPI M, HORSFIELD MA, MORRISSEY SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994; 44: 635-641.
34. PATY DW, OGER JJF, KASTRUKOFF LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185.
35. FILIPPINI G, COMI GC, COSI C, et al. Sensitivity and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol 1994: 241; 132-137.
36. MARRA TR. The clinical significance of the bifid or 'W' pattern reversal visual evoked potentials. Clinical Electroencephalography 1990; 21 (3): 162-167.